Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis
Clinical trial NCT03235752 · COMPLETED
Trial details
- NCT number
- NCT03235752
- Sponsor
- I-Mab Biopharma HongKong Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2020-12-21
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.